MUC1-C influences cell survival in lung adenocarcinoma Calu-3 cells after SARS-CoV-2 infection |
Kim, Dongbum
(Institute of Medical Science, College of Medicine, Hallym University)
Maharjan, Sony (Institute of Medical Science, College of Medicine, Hallym University) Kim, Jinsoo (Department of Microbiology, College of Medicine, Hallym University) Park, Sangkyu (Department of Biochemistry, College of Natural Sciences, Chungbuk National University) Park, Jeong-A (Department of Biochemistry, College of Natural Sciences, Chungbuk National University) Park, Byoung Kwon (Institute of Medical Science, College of Medicine, Hallym University) Lee, Younghee (Department of Biochemistry, College of Natural Sciences, Chungbuk National University) Kwon, Hyung-Joo (Institute of Medical Science, College of Medicine, Hallym University) |
1 | Linden SK, Sheng YH, Every AL et al (2009) MUC1 limits Helicobacter pylori infection both by steric hindrance and by acting as a releasable decoy. PLoS Pathog 5, e1000617 DOI |
2 | Kandeel M, Yamamoto M, Al-Taher A et al (2020) Small molecule inhibitors of Middle East respiratory syndrome coronavirus fusion by targeting cavities on heptad repeat trimers. Biomol Ther (Seoul) 28, 311-319 DOI |
3 | Raina D, Ahmad R, Joshi MD et al (2009) Direct targeting of the mucin 1 oncoprotein blocks survival and tumorigenicity of human breast carcinoma cells. Cancer Res 69, 5133-5141 DOI |
4 | Shin MJ, Kim DW, Choi YJ et al (2020) PEP-1-GLRX1 protein exhibits anti-inflammatory effects by inhibiting the activation of MAPK and NF-κB pathways in Raw 264.7 cells. BMB Rep 53, 106-111 DOI |
5 | Wu F, Zhao S, Yu B et al (2020) A new coronavirus associated with human respiratory disease in China. Nature 579, 265-269 DOI |
6 | Zhou P, Yang X, Wang X et al (2020) A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature 579, 270-273 DOI |
7 | Nath S and Mukherjee P (2014) MUC1: a multifaceted oncoprotein with a key role in cancer progression. Trends Mol Med 20, 332-342 DOI |
8 | Kaira K, Nakagawa K, Ohde Y et al (2012) Depolarized MUC1 expression is closely associated with hypoxic markers and poor outcome in resected non-small cell lung cancer. Int J Surg Pathol 20, 223-232 DOI |
9 | Li Y, Dinwiddie DL, Harrod KS, Jiang Y and Kim KC (2010) Anti-inflammatory effect of MUC1 during respiratory syncytial virus infection of lung epithelial cells in vitro. Am J Physiol Lung Cell Mol Physiol 298, L558-563 DOI |
10 | Banos-Lara Mdel R, Piao B and Guerrero-Plata A (2015) Differential mucin expression by respiratory syncytial virus and human metapneumovirus infection in human epithelial cells. Mediators Inflamm 2015, 347292 DOI |
11 | Luo J, Rizvi H, Preeshagul IR et al (2020) COVID-19 in patients with lung cancer. Ann Oncol 31, 1386-1396 DOI |
12 | Gao J, McConnell MJ, Yu B et al (2009) MUC1 is a downstream target of STAT3 and regulates lung cancer cell survival and invasion. Int J Oncol 35, 337-345 |
13 | Park BK, Maharjan S, Lee SI et al (2019) Generation and characterization of a monoclonal antibody against MERS-CoV targeting the spike protein using a synthetic peptide epitope-CpG-DNA-liposome complex. BMB Rep 52, 397-402 DOI |
14 | Kufe DW (2013) MUC1-C oncoprotein as a target in breast cancer: activation of signaling pathways and therapeutic approaches. Oncogene 32, 1073-1081 DOI |
15 | Bersanelli M (2020) Controversies about COVID-19 and anticancer treatment with immune checkpoint inhibitors. Immunotherapy 12, 269-273 DOI |
16 | Richardson S, Hirsch JS, Narasimhan M et al (2020) Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York city area. JAMA 323, 2052-2059 DOI |
17 | Yu J, Ouyang W and Chua MLK (2020) SARS-CoV-2 transmission in cancer patients of a tertiary hospital in Wuhan. JAMA Oncol 6, 1108-1110 DOI |
18 | Sidaway P (2020) COVID-19 and cancer: What we know so far. Nat Rev Clin Oncol 17, 336 DOI |
19 | Hollingsworth MA and Swanson BJ (2004) Mucins in cancer: protection and control of the cell surface. Nat Rev Cancer 4, 45-60 DOI |
20 | Levitin F, Stern O, Weiss M et al (2005) The MUC1 SEA module is a self-cleaving domain. J Biol Chem 280, 33374-33386 DOI |
21 | Macao B, Johansson DG, Hansson GC and Hard T (2006) Autoproteolysis coupled to protein folding in the SEA domain of the membrane-bound MUC1 mucin. Nat Struct Mol Biol 13, 71-76 DOI |
22 | Kufe DW (2009) Mucins in cancer: function, prognosis and therapy. Nat Rev Cancer 9, 874-885 DOI |
23 | Siegel RL, Miller KD and Jemal A (2020) Cancer statistics, 2020. CA Cancer J Clin 70, 7-30 DOI |
24 | Russano M, Vincenzi B, Tonini G, Tonini G and Santini D (2020) Coronavirus disease 2019 or lung cancer: What should we treat? J Thorac Oncol 15, e105-106 DOI |
25 | Thathiah A, Blobel CP and Carson DD (2003) Tumor necrosis factor-alpha converting enzyme/ADAM 17 mediates MUC1 shedding. J Biol Chem 278, 3386-3394 DOI |
26 | Zhang H, Huang Y and Xie C (2020) The treatment and outcome of a lung cancer patient infected with severe acute respiratory syndrome coronavirus-2. J Thorac Oncol 15, e63-64 DOI |
27 | Ahmad R, Rajabi H, Kosugi M et al (2011) MUC1-C oncoprotein promotes STAT3 activation in an autoinductive regulatory loop. Sci Signal 4, ra9 DOI |
28 | Huang L, Chen D, Liu D, Yin L, Kharbanda S and Kufe D (2005) MUC1 oncoprotein blocks glycogen synthase kinase 3beta-mediated phosphorylation and degradation of betacatenin. Cancer Res 65, 10413-10422 DOI |
29 | Awaya H, Takeshima Y, Yamasaki M and Inai K (2004) Expression of MUC1, MUC2, MUC5AC, and MUC6 in atypical adenomatous hyperplasia, bronchioloalveolar carcinoma, adenocarcinoma with mixed subtypes, and mucinous bronchioloalveolar carcinoma of the lung. Am J Clin Pathol 121, 644-653 DOI |
30 | Park BK, Kim D, Park S et al (2021) Differential signaling and virus production in Calu-3 cells and Vero cells upon SARS-CoV-infection. Biomol Ther (Seoul) 29, 273-281 DOI |
31 | Thathiah A and Carson DD (2004) Mt1-Mmp mediates muc1 shedding independent of tace/adam17. Biochem J 382, 363-373 DOI |
32 | Kaira K, Okumura T, Nakagawa K et al (2012) MUC1 expression in pulmonary metastatic tumors: a comparison of primary lung cancer. Pathol Oncol Res 18, 439-447 DOI |
33 | Xu M and Wang X (2017) Critical roles of mucin-1 in sensitivity of lung cancer cells to tumor necrosis factoralpha and dexamethasone. Cell Biol Toxicol 33, 361-371 DOI |
34 | Lu W, Liu X, Wang T et al (2021) Elevated MUC1 and MUC5AC mucin protein levels in airway mucus of critical Ill COVID-19 patients. J Med Virol 93, 582-584 DOI |
35 | Wu G, Kim D, Kim JN et al (2018) A mucin1 C-terminal subunit-directed monoclonal antibody targets overexpressed mucin1 in breast cancer. Theranostics 8, 78-91 DOI |
36 | Wu G, Maharjan S, Kim D et al (2018) A novel monoclonal antibody targets mucin1 and attenuates growth in pancreatic cancer model. Int J Mol Sci 19, 2004 DOI |
37 | Park BK, Kim J, Park S et al (2021) MERS-CoV and SARS-CoV-2 replication can be inhibited by targeting the interaction between the viral spike protein and the nucleocapsid protein. Theranostics 11, 3853-3867 DOI |